Table 1.

Cases of transfusion of blood products containing hepatitis E virus (HEV) RNA from this study.

Donor					Recipient					Outcome
Donor	Blood product	Viral load (IU/mL), genotype	Infectious dose (IU)	Anti-HEV IgM/IgG	Recipient, sex and age		Anti-HEV IgGa	Primary disease	Immuno-compromised	Follow-up period (days)	Outcome	HEV-PCR	Anti-HEV IgG
1	RBC (314 mL)	<25 GT 3	<2.50E+02	Negative	1	M, 23 years	Negative	Heart transplantation	Yes	134 days	No HEV infection	Negative	Negative
2	PC 1 (234 mL)	<25 GT 3	<4.68E+03	Negative	2	M, 76 years	Negative	Heart valve failure, atrial fibrillation	No	35 days	No HEV infection, died sepsis	Negative	Negative
	PC 2 (243 mL)		<4.86E+03		3	M, 54 years		Left ventricular heart failure	No	50 days	No HEV infection	Negative	Negative
3 donation 1	PC 1 (230 mL)	27.8 GT 3	5.12E+03	Negative	4	F, 26 years	Negative	Hypertrophic cardiomyopathy	No	16 days	No HEV infectionb	Negative	Negative
	PC 2 (254 mL)		5.65E+03
	Total		1.08E+04
3 donation 2	PC 1 (244 mL)	69.4 GT 3	1.35E+04	Negative	5	M, 72 years	Negative	Arrhythmia	No	NA	Died arrhythmia	NA	NA
	PC 2 (244 mL)		1.35E+04
	Total		2.71E+04
4	PC 1 (242 mL)	<25 GT 3	<3.97E+03	Negative	6	F, 79 years	Negative	Leukemia	Yes	NA	Died leukemia	NA	NA
	PC 2 (244 mL)		<4.00E+03
	Total		7.97E+03

^aAt the date of transfusion.

^bPatient no longer available.